Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Saturday, August 27 2016 7:14pm ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > MERCK & CO., INC. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
MERCK & CO., INC. Company Profile
Merck makes medicines for a number of maladies, from stuffy noses and asthma to hypertension and arthritis. The pharmaceutical giant's top prescription drugs include diabetes drugs Januvia and Janumet, anti-inflammatory Remicade, cholesterol combatants Vytorin and Zetia, and hypertension fighters Cozaar and Hyzaar. In addition, Merck makes childhood and adult vaccines for such diseases as measles, mumps, pneumonia, and shingles, as well as veterinary pharmaceuticals through Merck Animal Health. The company sold its OTC drug and personal care offerings, including Claritin allergy pills and Dr. Scholl's foot care products, to Bayer AG in 2014.
Headlines for MERCK & CO., INC.
Saturday links: bad intentions
- 1 hour, 30 minutes ago
Merck Offers Value and Steady Dividend Growth
- Wed Aug 24
Health-care sector trails broader market as pricing issues reinflamed
at MarketWatch - Wed Aug 24
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors
at TheStreet.com - Tue Aug 23
More Headlines...
More on MERCK & CO., INC.
Quote Insider
Chart Financials
Profile Analyst Ratings
Research    
Msgs    
Contact Information
Address: 2000 Galloping Hill Rd
Kenilworth, NJ 07033-1310
Phone:908-740-4000
Fax:908-735-1136
Financial Highlights
Fiscal Year End:December
Revenue (2014):42237.00 M
Revenue Growth (1 yr):(-4.10%)
Employees (2014):70,000
Employee Growth (1 yr):(-7.90%)
Key People
Chairman, President, and CEO: Kenneth C. Frazier
Senior Specialist, Managing Director: Salem Ahmed
Executive Director, Managing Director: Jaime Feced
Industry Information
Sector: Healthcare
Industry: Drug Manufacturers - Major
Top Competitors
GLAXOSMITHKLINE PLC (gsk)
PFIZER INC. (pfe)
Novartis AG
 


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?